Article Versions Notes

Enomoto H, Aizawa N, Hasegawa K, Ikeda N, Sakai Y, Yoh K, Takata R, Yuri Y, Kishino K, Shimono Y, et al. Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients. International Journal of Molecular Sciences. 2020; 21(9):3089. https://doi.org/10.3390/ijms21093089

Enomoto, Hirayuki, Nobuhiro Aizawa, Kunihiro Hasegawa, Naoto Ikeda, Yoshiyuki Sakai, Kazunori Yoh, Ryo Takata, Yukihisa Yuri, Kyohei Kishino, Yoshihiro Shimono, and et al. 2020. "Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients" International Journal of Molecular Sciences 21, no. 9: 3089. https://doi.org/10.3390/ijms21093089

Enomoto, H., Aizawa, N., Hasegawa, K., Ikeda, N., Sakai, Y., Yoh, K., Takata, R., Yuri, Y., Kishino, K., Shimono, Y., Ishii, N., Takashima, T., Nishimura, T., Nishikawa, H., Iwata, Y., Iijima, H., & Nishiguchi, S. (2020). Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients. International Journal of Molecular Sciences, 21(9), 3089. https://doi.org/10.3390/ijms21093089